Category: Newsletters

AXXE | Axxess Pharma, Inc. | Today’s Focus


Axxess Pharma, Inc. AXXE

We’re putting AXXE on our radars this morning, a new play with a chart that appears to have potential. As always when we focus on a new company, we’d first like to take a few minutes to familiarize ourselves with the business behind the stock.

Axxess Pharma has an expansive line which includes twenty-three prescription and non-prescription strength products, which are used in the treatment of a variety of ailments, including but not limited to: iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, and joint pain.

The company has been taking steps to make these products available to the public at an affordable price.

AXXE recently signed an agreement with a Mexican pharma company that will facilitate the distribution of its Soropon product to the Mexican population, which, according to President and CEO Dr. Daniel Bagi, is ” three times that of Canada’s and has a higher birth rate than Canada. AXXE is extremely pleased with the market possibilities in Mexico for Soropon and we anticipate robust sales for Soropon in Mexico, starting in 2014.”

That and more was covered yesterday when we conducted an Exclusive Interview with Dr. Bagi via our sister site, Stock Traders Talk. It covered a lot of important things, so be sure to take a few minutes to check that out on StockTradersTalk.com when it becomes available this afternoon!

AXXE EXCLUSIVE INTERVIEW
Available after 1:00PM today, only on Stock Traders Talk!

Now to go over the AXXE chart, for which we’ve provided the following video presentation:

Axxess has been awfully busy of late, making several news announcements already this month. Between its active approach to shareholder outreach via press release, as well as the CEO making the time to take part in our interview, we can see that this company places a high emphasis on transparency and visibility. To that end, if you read ahead to the PRs, we find that AXXE is actually making preparations for an uplisting to the OTC Bulletin Board.

SEPTEMBER PRESS RELEASES:

09.11.13: Axxess Pharma Inc. Initiates Next Step Towards Bulletin Board (OTCBB) Listing

09.09.13: AXXESS Pharma Inc. Signs Agreement With Top Mexican Pharmaceutical Company

09.04.13: Axxess Pharma Inc. Announces US Board Certified Cardiologist, Dr. Fred Maese as Senior Consultant

09.02.13: Axxess Pharma Inc. Announces MOU to Acquire Leading Canadian OTC Healthcare Company

More Info is available at:
www.axxesspharmainc.com

HNR, CETV & Extended Watchlist

Harvest Natural Resources, Inc. HNR

HNR set off our scanner this morning as this energy stock appears to be gapping up heavily in pre-market trading. Harvest announced this morning that it had entered into negotiations to sell the company’s Venezuelan assets, and spin off its remaining assets into a new company, a move that the CEO believes the proposed sale “affords the Company and its shareholders the ability to reap the benefits of our exceptional portfolio in the near term.” We’ll certainly be watching, as HNR is currently up 35% (a/o 8:30am).

In addition to this morning’s press release (below), the company will be holding a conference call tomorrow for anyone interested in learning more about the proposed transaction and its ramifications. To access the conference call, dial 800-344-6698 or 785-830-7979, five to ten minutes prior to the start time. At that time you will be asked to provide the conference number, which is 3073565. A recording of the conference call will also be available for replay at 719-457-0820, passcode 3073565 through September 17, 2013.

HOUSTON, Sept. 11, 2013 /PRNewswire via COMTEX/ — Harvest Natural Resources, Inc. (NYSE: HNR) today announced it has entered into exclusive negotiations with Pluspetrol Venezuela S.A., an entity belonging to one of the leading exploration and production companies in Latin America, to sell the outstanding shares of Harvest. >>> FULL REPORT

CEM Enterprises  CETV

We first called CETV on May 10th after it popped up on our Form-4 scan. At the time it was trading at 2.67, and in the roughly four months since that time, it has yet to dip below that price.

We are placing it back on watch for further gains as it is approaching its recent high of 4.85 (reached at the end of August), which represented a gain of 82% from our bottom. We’re interested to see if the stock can now break past that previous swing high for added gains. Conditions on the chart suggest this as a possibility, as you can see, the RSI is rumbling toward the powerzone, we have a potential Golden Cross of the 50 & 200DMA currently setting up.

Extended Watchlist:
AQUM, VTUS, PSTI, DVAX

Blue Horseshoe Stocks: FREE & Extended Watchlist

FreeSeas, Inc. FREE

FREE set off our volume scanners yesterday, a stock that had recently been trading in the .17-.26 range until a surge of buying pushed it through a triple top, breaking recent resistance at the 50DMA with authority.

Whenever our searches turn up a momentous play like this one, we have to give it our attention. As we pointed out on the chart below, the next areas of resistance come at .33 and .38, and other indicators appear to be favorable. FREE is definitely going to be on our watchlists as we cruise into midweek.


Extended Watchlist:
PLUG, INO, DRYS, LLEN, NEWL, NVIV